Haemonetics Corp
NYSE:HAE

  • LAST PRICE
    87.9150
  • TODAY'S CHANGE (%)
    -0.5450 (-0.6161%)
  • Bid / Lots
    87.5100/ 7
  • Ask / Lots
    88.3400/ 1
  • Open / Previous Close
    88.3500 / 88.4600
  • Day Range
    87.5000
    88.7250
  • 52 Week Range
    70.2500
    97.9700
  • Volume
    11,902

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
HAE
Haemonetics Corp
4.3B
36.5x
+17.09%
GH
Guardant Health Inc
4.0B
-8.1x
---
ICUI
ICU Medical Inc
4.1B
-36.3x
---
NEOG
Neogen Corp
3.2B
-136.4x
---
LIVN
LivaNova PLC
2.8B
120.8x
---
NVST
Envista Holdings Corp
3.7B
-2.8x
---
As of 2024-11-26

Company Information

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Company’s Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.

Contact Information

Headquarters
125 Summer StreetBOSTON, MA, United States 02110
Phone
781-848-7100
Fax
---

Executives

Independent Chairman of the Board
Ellen Zane
President, Chief Executive Officer
Christopher Simon
Executive Vice President, Chief Financial Officer
James D'arecca
President - Global Plasma and Blood Center
Roy Galvin
President - Global Hospital
Stewart Strong

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$4.3B
Revenue (TTM)
$1.4B
Shares Outstanding
50.2M
Haemonetics Corp does not pay a dividend.
Beta
0.38
EPS
$2.41
Book Value
$18.90
P/E Ratio
36.5x
Price/Sales (TTM)
3.2
Price/Cash Flow (TTM)
18.4x
Operating Margin
12.30%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.